Interactions Among Non-Coding RNAs and mRNAs in the Trigeminal Ganglion Associated with Neuropathic Pain
DOI: https://doi.org/10.2147/JPR.S382692
IF: 2.8319
2022-09-22
Journal of Pain Research
Abstract:Zhong-Han Fang, 1, 2 Hong-Lin Liao, 1, 2 Qing-Feng Tang, 1, 2 Ya-Jing Liu, 1, 2 Yan-Yan Zhang, 1, 2 Jiu Lin, 1, 2 Hao-Peng Yu, 3 Cheng Zhou, 4 Chun-Jie Li, 1, 5 Fei Liu, 1, 2, &ast Jie-Fei Shen 1, 2, &ast 1 State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, National Center for Stomatology, West China School of Stomatology, Sichuan University, Chengdu, People's Republic of China; 2 Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, People's Republic of China; 3 West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 4 Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 5 Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Liu; Jie-Fei Shen, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, People's Republic of China, Email ; Background: Recent studies have demonstrated the contribution of non-coding RNAs (ncRNAs) to neuropathic pain. However, the expression profile of ncRNAs in the trigeminal ganglion (TG) and their functional mechanism underlying trigeminal neuropathic pain are still unclear. Methods: In the present study, the trigeminal neuropathic pain model induced by chronic constriction injury of the infraorbital nerve (CCI-ION) was used to study the expression profile and potential regulatory mechanism of miRNAs, lncRNAs, circRNAs, and mRNAs in the TG by RNA-sequencing (RNA-seq) and bioinformatics analysis. CCI-ION mice suffered from mechanical allodynia from 3 days to 28 days after surgery. Results: The RNA-seq results discovered 67 miRNAs, 216 lncRNAs, 14 circRNAs, 595 mRNAs, and 421 genes were differentially expressed (DE) in the TG of CCI-ION mice 7 days after surgery. And 39 DEGs were known pain genes. Besides, 5 and 35 pain-related DE mRNAs could be targeted by 6 DE miRNAs and 107 DE lncRNAs, respectively. And 23 pain-related DEGs had protein–protein interactions (PPI) with each other. GO analysis indicated membrane-related cell components and binding-related molecular functions were significantly enriched. KEGG analysis showed that nociception-related signaling pathways were significantly enriched for DE ncRNAs and DEGs. Finally, the competing endogenous RNA (ceRNA) regulatory network of DE lncRNA/DE circRNA-DE miRNA-DE mRNA existed in the TG of mice with trigeminal neuropathic pain. Conclusion: Our findings demonstrate ncRNAs are involved in the development of trigeminal neuropathic pain, possibly through the ceRNA mechanism, which brings a new bright into the study of trigeminal neuropathic pain and the development of novel treatments targeting ncRNAs. Keywords: trigeminal neuropathic pain, non-coding RNAs, RNA-sequencing, trigeminal ganglion, trigeminal nerve injury, bioinformatics Trigeminal neuropathic pain is a severe health problem and is difficult to treat because of its complex mechanisms. It often occurs after injuries to the trigeminal sensory fibers induced by trauma and tooth iatrogenic injuries from dental treatments, such as local anesthetic injections, root canal therapies, extractions, oral surgery, dental implants, orthognathic surgery, and other invasive procedures. 1,2 Although lots of potential intervention molecular targets in the trigeminal ganglion (TG) for treating trigeminal neuropathic pain have been found, 3 for instance, multiple groups of molecules (ATP, glutamate, SP, IL-1β, and TNF-α), receptors (P2X, NMDAR, NK1, and GPCRs), ion channels (voltage-gated potassium channels and voltage-gated calcium channels), and intracellular signaling pathways (MAPKs, PKC, PKA), 3–5 consistently effective treatment options are still not available. 3,6 Therefore, more preclinical research is expected to elucidate the molecular mechanism underlying trigeminal neuropathic pain and identify novel therapeutic targets to develop a more effective treatment for trigeminal neuropathic pain. In recent years, emerging evidence suggests that non-coding ribose nucleic acids (ncRNAs) play a vital role in the pathophysiological process of neuropathic pain, 7,8 which brings novel landscapes for the diagnosis and treatment of trig -Abstract Truncated-
clinical neurology